Board of Directors


Jim Foght, PhD, Chairman
Dr. Foght has over 40 years experience in the healthcare and life sciences industries. He was co-founder Dupont Pharmaceuticals, founder and President of Vector Securities, a premier investment banking firm specializing in early-stage biotechnology ventures. He holds many advisory positions. He is currently Chairman of the Board of Directors of IllinoisVENTURES LLC, an organization that commercializes University of Illinois technologies, and on the investment committee of the Vector Later-Stage Equity Funds and Board of Director Illinois Emerging Technology Fund.

John Presutti, MBA
John served as a marketing and business development executive at GD Searle and Curatek. John has over 30 years of experience in pharmaceutical business development, marketing and finance. He has successfully taken drugs through the regulatory and commercialization process, both for big pharma and as an independent entrepreneur.

Tom Judge, JD, MBA
Tom has 20 years of experience in transactional law and practice (venture capital, joint ventures, securities and M&A). He was previously at Sidley & Austin and Michael, Best & Friedrich. Tom has co-authored three books on management, strategy and investment. Tom is acting General Counsel for the Company as well.

Elijah M. Bolotin, PhD.
Elijah is the management representative to the Board. See link for details.